(Q41431623)

30 September 2017

Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates (English)

1 reference

30 September 2017

Matthias Schmid

4

0 references

Kai-Uwe Eckardt

12

object named as

Kai-Uwe Eckardt

1 reference

30 September 2017

Markus P Schneider

1

1 reference

30 September 2017

Silvia Hübner

2

1 reference

30 September 2017

Stephanie I Titze

3

1 reference

30 September 2017

Jennifer Nadal

5

1 reference

30 September 2017

Georg Schlieper

6

1 reference

30 September 2017

Martin Busch

7

1 reference

30 September 2017

Seema Baid-Agrawal

8

1 reference

30 September 2017

Vera Krane

9

1 reference

30 September 2017

Christoph Wanner

10

1 reference

30 September 2017

Florian Kronenberg

11

1 reference

30 September 2017

language of work or name

English

0 references

publication date

2 September 2015

1 reference

30 September 2017

1 reference

30 September 2017

88

1 reference

30 September 2017

6

1 reference

30 September 2017

1411-1418

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2015.246

30 September 2017

0 references

cites work

Association between LDL-C and risk of myocardial infarction in CKD

1 reference

12 December 2020

An updated coronary risk profile. A statement for health professionals.

1 reference

12 December 2020

The Framingham predictive instrument in chronic kidney disease.

1 reference

12 December 2020

Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study).

1 reference

12 December 2020

Nurse practitioners improve quality of care in chronic kidney disease: two-year results of a randomised study.

1 reference

12 December 2020

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

1 reference

12 December 2020

Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease.

1 reference

12 December 2020

Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study

1 reference

12 December 2020

Contrasting Cholesterol Management Guidelines for Adults with CKD.

1 reference

12 December 2020

Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations

1 reference

12 December 2020

Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis

1 reference

12 December 2020

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts

1 reference

12 December 2020

A new equation to estimate glomerular filtration rate

1 reference

12 December 2020

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

12 December 2020

Lipid re-screening: what is the best measure and interval?

1 reference

12 December 2020

Summary of Recommendation Statements

1 reference

12 December 2020

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

1 reference

12 December 2020

Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial

1 reference

12 December 2020

Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function

1 reference

12 December 2020

Monitoring cholesterol levels: measurement error or true change?

1 reference

12 December 2020

KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient

1 reference

12 December 2020

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

1 reference

12 December 2020

Three reasons to abandon low-density lipoprotein targets: an open letter to the Adult Treatment Panel IV of the National Institutes of Health

1 reference

12 December 2020

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

1 reference

12 December 2020

Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort

1 reference

12 December 2020

Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease

1 reference

12 December 2020

The German Chronic Kidney Disease (GCKD) study: design and methods.

1 reference

12 December 2020

Identifiers

DOI

10.1038/KI.2015.246

1 reference

Dimensions Publication ID

30 September 2017

0 references

1 reference